Table 2.
Correlations between adipokines and other parameters in patients with COPD (n = 43).
NUCB2/nesfatin-1 | Visfatin | |
---|---|---|
FEV1 (% pred) | rho = 0.097 | r = 0.127 |
P = 0.535 | P = 0.422 | |
| ||
FENO0.05 (ppb) | rho = −0.035 | r = 0.040 |
P = 0.823 | P = 0.802 | |
| ||
Hb-D L,CO/V A (% pred) | rho = −0.103 | r = −0.369 |
P = 0.512 | P = 0.016 | |
| ||
Emphysema percentage (%) | rho = 0.076 | r = 0.204 |
P = 0.626 | P = 0.194 | |
| ||
IL-6 (pg/mL) | rho = 0.401 | r = 0.341 |
P = 0.008 | P = 0.027 | |
| ||
IL-8 (pg/mL) | rho = 0.321 | r = 0.121 |
P = 0.036 | P = 0.443 | |
| ||
TNF-α (pg/mL) | rho = 0.329 | r = 0.305 |
P = 0.033 | P = 0.052 |
The distribution of nesfatin-1 was skewed while visfatin was normally distributed; therefore Spearman's rho and Pearson's r were used to analyze the correlations of NUCB2/nesfatin-1 and visfatin, respectively, to the other parameters presented.
FEV1: forced expiratory volume in 1 second; FENO0.05: fractional exhaled nitric oxide concentration at exhalation flow rate of 50 mL/s; Hb-D L,CO/V A: diffusing capacity for carbon monoxide per unit of alveolar volume standardized for haemoglobin; IL: interleukin; TNF: tumor necrosis factor.